Literature DB >> 19968493

Constitutively active Akt contributes to vincristine resistance in human retinoblastoma cells.

Hao Zhang1, Bin Li, Shu-wei Bai, Hui-juan Wang.   

Abstract

Akt mediates survival signals which preserve various cancer cells from apoptosis. Its correlation with chemoresistance of cancer cells has attracted much attention. But how Akt affects vincristine-induced cell death in retinoblastoma is unknown. Here we show that Akt activity is involved in vincristine-induced cytotoxicity in retinoblastoma SO-Rb50 cells. Inhibition of Akt can decrease the survival of both sensitive and vincristine-resistant SO-Rb50 cells and increase the sensitivity of both cell lines to vincristine by enhancing the cell apoptosis and increasing the cellular accumulation of the drug. Akt may be a target for reducing drug resistance that improves the treatment for retinoblastoma.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19968493     DOI: 10.3109/07357900903179641

Source DB:  PubMed          Journal:  Cancer Invest        ISSN: 0735-7907            Impact factor:   2.176


  5 in total

1.  Antitumor activity of celastrol nanoparticles in a xenograft retinoblastoma tumor model.

Authors:  Zhanrong Li; Xianghua Wu; Jingguo Li; Lin Yao; Limei Sun; Yingying Shi; Wenxin Zhang; Jianxian Lin; Dan Liang; Yongping Li
Journal:  Int J Nanomedicine       Date:  2012-05-09

2.  Variable expression of PIK3R3 and PTEN in Ewing Sarcoma impacts oncogenic phenotypes.

Authors:  Brian F Niemeyer; Janet K Parrish; Nicole S Spoelstra; Teresa Joyal; Jennifer K Richer; Paul Jedlicka
Journal:  PLoS One       Date:  2015-01-20       Impact factor: 3.240

3.  Delineating the Role of βIV-Tubulins in Pancreatic Cancer: βIVb-Tubulin Inhibition Sensitizes Pancreatic Cancer Cells to Vinca Alkaloids.

Authors:  G Sharbeen; J McCarroll; J Liu; J Youkhana; L F Limbri; A V Biankin; A Johns; M Kavallaris; D Goldstein; P A Phillips
Journal:  Neoplasia       Date:  2016-11-24       Impact factor: 5.715

4.  Early Mechanisms of Chemoresistance in Retinoblastoma.

Authors:  Michelle G Zhang; Jeffim N Kuznetsoff; Dawn A Owens; Ryan A Gallo; Karthik Kalahasty; Anthony M Cruz; Stefan Kurtenbach; Zelia M Correa; Daniel Pelaez; J William Harbour
Journal:  Cancers (Basel)       Date:  2022-10-10       Impact factor: 6.575

5.  Combined treatment with an oncolytic adenovirus and antitumor activity of vincristine against retinoblastoma cells.

Authors:  Xin Song; Haibo Wang; Renbing Jia; Biyun Cun; Xiaoping Zhao; Yixiong Zhou; Xiaofang Xu; Guanxiang Qian; Shengfang Ge; Xianqun Fan
Journal:  Int J Mol Sci       Date:  2012-08-27       Impact factor: 6.208

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.